Image depicting a graph related to Google Analytics metrics, illustrating data trends relevant to the 340B Program compliance and healthcare consulting services provided by Ponaman Healthcare Consulting.

340B Program Insights: Regulatory Updates and Compliance News

After a brief posting delay, HRSA’s Request for Information (RFI) on a potential new 340B rebate model is now officially open for comment. The RFI deadline has been extended to April 20, 2026. At the same time, HRSA released a separate Information Collection Request (ICR) estimating the administrative burden...

We want to share a brief update on developments since our last communication regarding the federal court’s decision to halt HRSA’s 340B rebate pilot. The pause remains in effect. Following the December 29 court order blocking the rebate pilot from taking effect, HRSA formally paused implementation on...

The Real Cost of the 340B Rebate Model: Why Cash Flow Planning Can’t Wait The 340B Rebate Model Pilot represents a major shift in how covered entities manage their pharmacy programs. Scheduled for January 1, 2026, certain high-cost drugs will no longer come with upfront 340B...

HRSA’s 340B Rebate Model pilot remains on schedule for January 1, 2026, despite the ongoing federal government shutdown. Beacon Channel Management has issued updated manufacturer guidance, revised its FAQ on November 3, and opened registration for all covered entities. Key Program Updates Implementation Date: January 1, 2026...

The 340B Program is facing one of its biggest structural shifts in decades. Potentially starting January 1, 2026, or closely thereafter, HRSA and CMS plan to launch the 340B Rebate Model Pilot, aligning it with Medicare’s Drug Price Negotiation Program (MDPNP) under the Inflation Reduction...